RC-P
Showing 1 - 25 of 8,343
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial (Asparaginase Erwinia Chrysanthemi (recombinant))
Approved for marketing
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Asparaginase Erwinia Chrysanthemi (recombinant)
- (no location specified)
Jul 27, 2021
Urothelial Carcinoma Trial in United States (disitamab vedotin, pembrolizumab)
Recruiting
- Urothelial Carcinoma
- disitamab vedotin
- pembrolizumab
-
Los Angeles, California
- +17 more
Jan 3, 2023
Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia Trial in Canada, United States (IM JZP-458, IV JZP-458)
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Leukemia
- IM JZP-458
- IV JZP-458
-
Birmingham, Alabama
- +73 more
Aug 3, 2022
MDD With Anxious Distress Trial in Worldwide (JNJ-61393215, Placebo)
Completed
- Major Depressive Disorder With Anxious Distress
- JNJ-61393215
- Placebo
-
Garden Grove, California
- +34 more
Sep 2, 2022
Observational Study in COVID-19 Patients Treated With Remdesivir
Recruiting
- Hospitalization
- no experimental intervention
-
Acqui Terme, (al), Italy
- +29 more
Feb 14, 2022
Schizophrenia, Schizoaffective Disorder Trial in Worldwide (RO6889450, Placebo, Risperidone)
Terminated
- Schizophrenia, Schizoaffective Disorder
- RO6889450
- +2 more
-
Little Rock, Arkansas
- +49 more
Jul 14, 2022
Schizophrenia Trial in Worldwide (PP6M injection Dose 1, PP6M injection Dose 2)
Completed
- Schizophrenia
- PP6M injection Dose 1
- PP6M injection Dose 2
-
Ciudad Autónoma De Buenos Aires, Argentina
- +29 more
Jul 14, 2022
Relapsing Remitting Multiple Sclerosis Trial in Worldwide (, orelabrutinib)
Recruiting
- Relapsing Remitting Multiple Sclerosis
- placebo
- orelabrutinib
-
Ormond Beach, Florida
- +41 more
Jan 28, 2022
Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53 Trial in Worldwide (APR-246, Carboplatin and
Completed
- Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53
- APR-246
- Carboplatin and Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
-
Los Angeles, California
- +54 more
Sep 20, 2022
Chronic Myeloid Leukemia, Chronic Phase, CML, Chronic Phase, CML, Refractory Trial in Worldwide (Radotinib HCl)
Recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- +3 more
- Radotinib HCl
-
Uijeongbu-si, Gyeonggi-do, Korea, Republic of
- +17 more
Jan 3, 2022
Xerosis Cutis Trial in Blauvelt (IDL lotion, Control lotion)
Completed
- Xerosis Cutis
- IDL lotion
- Control lotion
-
Blauvelt, New YorkCantor Research Laboratory
Jan 31, 2020
Muscle Invasive Bladder Cancer Trial in Worldwide (biological, procedure, drug)
Recruiting
- Muscle Invasive Bladder Cancer
- Pembrolizumab
- +4 more
-
Phoenix, Arizona
- +136 more
Aug 5, 2022
Muscle-Invasive Bladder Carcinoma, Chemo Effect, Surgery Trial in Rome (cisplatin based neoadjuvant chemo, Radical cystectomy
Recruiting
- Muscle-Invasive Bladder Carcinoma
- +2 more
- cisplatin based neoadjuvant chemotherapy
- Radical cystectomy alone
-
Rome, ItalyRiccardo Mastroianni
Mar 8, 2023
Meaning and (Cost-)Effectiveness of Dutch Recovery Colleges
Recruiting
- Severe Mental Illness
- Mental Vulnerabilities
- Recovery College participation
-
Apeldoorn, Netherlands
- +3 more
Nov 9, 2022
Hypoparathyroidism Trial in Worldwide (rhPTH(1-84), Placebo)
Completed
- Hypoparathyroidism
- rhPTH(1-84)
- Placebo
-
Chicago, Illinois
- +39 more
May 23, 2022
Radical Cure With Tafenoquine or Primaquine After
Not yet recruiting
- Malaria, Vivax
- Training on revised algorithm
- +6 more
- (no location specified)
Dec 23, 2022
Rotator Cuff Tear Trial in Jerusalem (Dextrose 50)
Withdrawn
- Rotator Cuff Tear
- Dextrose 50
-
Jerusalem, IsraelPain Unit, Hadassah Medical Center
Aug 20, 2022
Pediatric Enhanced Recovery After Cardiac Surgery
Recruiting
- ERAS
- +2 more
- enhanced recovery
-
Edmonton, Alberta, CanadaUniversity of Alberta
Dec 16, 2022
Patients With Atrial Fibrillation and Cancer
Active, not recruiting
- Atrial Fibrillation
- Cancer
-
Aalst, Belgium
- +118 more
Mar 15, 2022
Restorelle® Mesh Versus Native Tissue Repair for Prolapse
Completed
- Pelvic Organ Prolapse
- Restorelle Direct Fix A
- +3 more
-
Agoura Hills, California
- +48 more
Jan 25, 2022
Bladder Cancer Trial in Nanjing (Reduce surgical procedures)
Recruiting
- Bladder Cancer
- Reduce surgical procedures
-
Nanjing, Jiangsu, ChinaThe first affiliated hospital of Nanjing Medical University
Nov 9, 2021